Moderna, Inc. Price Today
Moderna, Inc.
MRNA
Healthcare
$41.24B
💰
Market Cap
9.3
💸
Price to Earnings
$11.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
13 |
Strong Buy |
4 |
Hold |
10 |
Sell |
2 |
Strong Sell |
0 |
MRNA Price Forecast Target
108.2 👉 390.0 +260%
MRNA EPS Forecast
11.6 👉 -4.4 +-138%
Financials
Profit Margin
11 %
Revenue Growth
-92.8 %
Dividend
$ 0
Held Percent
9.7% - Insiders
69.5% - Institutions
20.8% - Public
Major Fund Holders
-
💰 Baillie Gifford and Company $5.6B
-
💰 Vanguard Group Inc $4.2B
-
💰 Blackrock Inc. $3.9B
-
💰 State Street Corporation $2.2B
-
💰 Flagship Pioneering Inc. $2.0B
Stock Ideas
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Louis Bacon Portfolio
Louis Bacon is the founder of Moore Capital Management and is one of the famous traders of the past two decades. His personal wealth is more than $1.5 Billion and had more than $15 Billion in AUM. He has an MBA degree from Columbia Business School.
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…📮FAQ
Some Frequently Asked Questions.
The Moderna, Inc. industry is Biotechnology
The Moderna, Inc. sector is Healthcare
The Moderna, Inc. forecasted predicted Price to Earnings PE ratio is -24.5
The Moderna, Inc. Price to Earnings PE ratio is 9.3
The Market Capitalization of Moderna, Inc. is $41.24B
There are total of 343568541 float shares with 69.5% held by Institutions and 9.7% held by insiders
The MModerna, Inc. forecasted Earnings per Share EPS is $-4.4
The Moderna, Inc. Earnings per Share EPS is 11.6
The Moderna, Inc. company has $10552000000 gross profits with 11 profit margins
The Moderna, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The Moderna, Inc. Revenue is $10654000128 with -0.928 revenue growth
The price target for Moderna, Inc. stock is $390.0 for the high target and $74.4 for the low target
The consensus analyst recommendations for Moderna, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Moderna, Inc. is Buy, with the following breakdown:
- Buy: 13
- Strong Buy: 4
- Hold: 10
- Sell: 2
- Strong Sell: 0
The Beta of Moderna, Inc. is 1.6
The dividend of Moderna, Inc. is $0
The dividend yield of Moderna, Inc. is 0%
The biggest institutional and mutual fund holders of Moderna, Inc. stock are
- Baillie Gifford and Company
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
The Moderna, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0